Quality of life assessment of relapsing-remitting multiple sclerosis patients on long-term treatment with Betaferon

被引：0
|
作者：
Davidescu, I.
Damian, G.
机构：
[1] Colentina Hosp, Dept Neurol, Bucharest, Romania
[2] UMF Carol Davila, Bucharest, Romania
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：129 / 129
页数：1
相关论文
共 50 条
  • [21] The impact of long-term treatment with disease modifying therapy on disability progression in relapsing-remitting multiple sclerosis patients
    Carra, Adriana J.
    Onaha, Patricia S.
    Sinay, Vladimiro
    Halfon, Mario J.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S36 - S36
  • [22] Successful Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis with Interferon β-1b
    Schmidt, S.
    AKTUELLE NEUROLOGIE, 2012, 39 : S22 - S23
  • [23] Effectiveness and safety of long-term fingolimod treatment in relapsing-remitting multiple sclerosis patients with highly active disease
    Vorobeychik, G.
    Devonshire, V.
    Freedman, M. S.
    Grand'Maison, F.
    Selchen, D.
    Schecter, R.
    Haddad, P.
    Tenenbaum, N.
    Bhatt, A.
    Pimentel, R.
    Kappos, L.
    Cohen, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 891 - 892
  • [24] A Long-term Experience with Fingolimod: Evaluation of Safety, Disability, and Treatment Satisfaction in Patients with Relapsing-Remitting Multiple Sclerosis
    Tenenbaum, Nadia
    Cohen, Jeffrey
    Bhatt, Alit
    Pimentel, Ron
    Kappos, Ludwig
    NEUROLOGY, 2018, 90
  • [25] Long-term effect of natalizumab in relapsing-remitting multiple sclerosis: TYSTEN cohort
    Bigaut, K.
    Fabacher, T.
    Kremer, L.
    Ongagna, J. -C.
    Kwiat-Kowski, A.
    Sellal, F.
    Ferriby, D.
    Courtois, S.
    Vermersch, P.
    Collongues, N.
    Zephir, H.
    De Seze, J.
    Outteryck, O.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 536 - 536
  • [26] Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis
    Boster, Aaron L.
    Ford, Corey C.
    Neudorfer, Orit
    Gilgun-Sherki, Yossi
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (06) : 575 - 586
  • [27] Interferons in relapsing-remitting multiple sclerosis -: Are there benefits from long-term use?
    Fernández, O
    CNS DRUGS, 2004, 18 (15) : 1057 - 1070
  • [28] Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis
    Portaccio, E
    Zipoli, V
    Siracusa, G
    Sorbi, S
    Amato, MP
    MULTIPLE SCLEROSIS, 2005, 11 : S158 - S158
  • [29] Quality of life in carers of patients with relapsing-remitting multiple sclerosis: a pilot study
    Gigineishvili, D.
    Kareli, M.
    Tevzadze, A.
    Karakov, S.
    Kiziria, M.
    Tsiskaridze, A.
    Shakarishvili, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 669 - 669
  • [30] Impact of relapsing-remitting multiple sclerosis on sleep quality and quality of life
    Popovic, Z.
    Jovicic, M.
    Zubonja, T. Mirosevic
    Janculjak, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 504 - 505
12345